BCM
CC icon

Bluefin Capital Management’s Chemours CC Stock Holding History

Bluefin Capital Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-114,500
Closed -$57K – 496
2017
Q2 		$57K Buy
+114,500
New +$4.52M 0.01% 404
2016
Q1 		– Sell
-299,800
Closed -$67K – 503
2015
Q4 		$67K Buy
+299,800
New +$1.92M 0.01% 489

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bluefin Capital Management's CC Position: Q1 2022 in Review

Bluefin Capital Management sold out of Chemours (CC) in Q1 2022, closing a stake of 7,700 shares — an estimated $258K sold.

Bluefin Capital Management first reported a position in CC in Q4 2015 and held it in 7 quarters. The position peaked at $5.65M in Q1 2017. 482 funds tracked by Wall St. Rank hold CC as of Q1 2022.

  • Bluefin Capital Management reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 7,700 Chemours shares in Q1 2022, an estimated $258K.
  • Bluefin Capital Management first reported a position in Chemours in Q4 2015 and held it in 7 quarters.
  • Bluefin Capital Management's Chemours position peaked at $5.65M in Q1 2017.
  • 482 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Bluefin Capital Management's 13F filing for Q1 2022, filed 16 May 2022.